Cannabis and cannabis-derived compounds: Quality considerations for clinical research guidance for industry
The FDA recently released guidance related to clinical research on human drugs containing cannabis or cannabis-derived compounds....
The FDA recently released guidance related to clinical research on human drugs containing cannabis or cannabis-derived compounds....
Exploring ways clinical trial leaders and organizers can improve the patient experience....
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
After completing difficult bouts of chemotherapy, Larson contacted the UW Health | Carbone Cancer Center to see which clinical trials he could explore....
Doing more to acknowledge the important role of clinical trials participants could help with recruitment....
An analysis of the pandemic's impacts on broader organizational and sector level dynamics in clinical research such as competitor collaboration, globalization, industry goodwill, public health, supply chain, and workplace environment....
Increased diversity in clinical trials should be a requirement, not a suggestion....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
UW Health's Dr. Nathaniel Chin discusses the impact of lecanemab and the future of Alzheimer's and dementia-related clinical research....
The need for more diversity in clinical trials is being increasingly emphasized, but more creative and collaborative recruitment approaches may be needed to make trials more diverse....